Effects of uridine on cardiomyocyte mitochondrial function in SHR in the early stage of hypertension
Аннотация
The development of heart failure due to hypertension is known to be accompanied by various mitochondrial dysfunctions. It has previously been established that the pyrimidine nucleoside uridine (U) exerts a protective effect on the structural and functional parameters of mitochondria under various pathological conditions. This study aimed to evaluate the functional state of mitochondria in spontaneously hypertensive rats (SHR) in the stage of the early hypertension and to investigate the effect of uridine on mitochondrial dysfunction associated with this pathology. A 30-mg/kg uridine was found not to affect blood pressure (BP) dynamics in SHR and WKY (Wistar Kyoto) animals. In SHR, the levels of thiobarbituric acid-reactive substances (TBARS) in serum increased compared to WKY. SHR cardiac mitochondria showed decrease in respiratory control ratio compared to WKY mitochondria. Injection of uridine was accompanied by a respiratory rate decrease in the SHR + U group relative to the control. Uridine increased the levels of respiratory complexes IV and V subunits in SHR. The rate of H 2 O 2 generation in SHR cardiac mitochondria to be restored to the control levels after uridine administration. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities in SHR decreased; herewith, uridine caused no statistically significant changes in SOD, GPx, and catalase (CAT) activities. This nucleoside was found not to affect the levels of mitochondrial ATP-sensitive potassium channel (MITOK) subunits in both animal strains studied. Thus, uridine exhibited antioxidant effects, contributing to partial normalization of cardiac mitochondrial function in SHR in the early stages of hypertension. This was probably due to modulation of the activity of mitochondrial transport systems, without the risk of hypertensive effects. These data justify further research into uridine as a cardiomyocyte protector. Hypertension, mitochondrial dysfunctions, uridine, oxidative stress, MITOK, SHR rats, OXPHOS.